Nav: Home

Narrow spectrum antibiotic kills pathogens without killing good bacteria

May 09, 2016

Washington, DC - May 9, 2016 - The problem with broad spectrum antibiotics is that they kill good bacteria along with the bad. But a new antibiotic, Debio 1452, which is narrowly targeted at Staphilococcal pathogens, caused almost no harm to the gut microbiome of mouse models, while conventional broad spectrum antibiotics caused major damage. The research is published in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.

In the study, the investigators treated groups of five mice with either Debio 1452, or one of various commonly used, broad spectrum antibiotics, said corresponding author Charles O. Rock, PhD, Director of the Protein Production Facility in the Infectious Diseases Department, St. Jude Children's Research Hospital, Memphis, TN. Treatment lasted 10 days, followed by a 27 day recovery period, during which times feces--proxies for the gut microbiome--were collected to analyze diversity and abundance of bacterial species. The investigators used next generation sequencing technology to identify the bacterial species, and real-time PCR to determine abundance.

Abundance and diversity remained nearly stable under treatment with Debio 1452. In contrast, "Linezolid, clindamycin, and amoxicillin treatment all caused a ~4,000-fold decrease in the gut bacterial abundance at the second day of treatment that persisted until the end of the treatment," according to the report. (Moxifloxacin caused a much smaller, but still significant reduction in abundance, and recovery was much faster.) Additionally, major changes in species composition of the gut microbiome occurred during treatment with the broad spectrum antibiotics, said Rock.

"These results demonstrate that the pathogen-selective approach to antibiotic development is an effective way to minimize collateral damage to the microbiome," said Rock.

Motivating the research, Rock said that "The patients at St. Jude Children's Research Hospital are often on extended antibiotic therapy during their cancer treatment. Children with developing immune systems and patients on long-term antibiotic regimes are most susceptible to the adverse consequences arising from a devastated gut microbiome."

"Broad spectrum antibiotic treatments save countless lives every year, but also contribute to the modern plagues of metabolic and autoimmune diseases," said Rock. "Our research shows that a pathogen selective approach to antibiotic development results in drugs that fight bacterial infections without promoting these adverse side effects."
The American Society for Microbiology is the largest single life science society, composed of over 47,000 scientists and health professionals. ASM's mission is to promote and advance the microbial sciences.ASM advances the microbial sciences through conferences, publications, certifications and educational opportunities. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.

American Society for Microbiology

Related Antibiotic Articles:

Why using antibiotic eye drops for pinkeye is the wrong way to go
Using antibiotic eye drops for pinkeye is often the wrong way to go but 60 percent of patients nationwide are getting prescriptions for the common eye infection that typically clears up on its own.
Comparison of antibiotic treatments for cellulitis
Among patients with uncomplicated cellulitis, the use of an antibiotic regimen with activity against MRSA did not result in higher rates of clinical resolution compared to an antibiotic lacking MRSA activity; however, certain findings suggest further research may be needed to confirm these results, according to a study published by JAMA.
Antibiotic therapy for nearly 1 in 4 adults with pneumonia does not work
Approximately one in four (22.1 percent) adults prescribed an antibiotic in an outpatient setting (such as a doctor's office) for community-acquired pneumonia does not respond to treatment, according to a new study presented at the 2017 American Thoracic Society International Conference.
Key to 'superbug' antibiotic resistance discovered
An international study led by Monash University's Biomedicine Discovery Institute has discovered the molecular mechanism by which the potentially deadly superbug 'Golden Staph' evades antibiotic treatment, providing the first important clues on how to counter superbug antibiotic resistance.
Lighting up antibiotic resistance
Carbapenems are among the 'antibiotics of last resort' and can fight infections for which other drugs have long lost their effectiveness.
More Antibiotic News and Antibiotic Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Teaching For Better Humans
More than test scores or good grades — what do kids need to prepare them for the future? This hour, guest host Manoush Zomorodi and TED speakers explore how to help children grow into better humans, in and out of the classroom. Guests include educators Olympia Della Flora and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#535 Superior
Apologies for the delay getting this week's episode out! A technical glitch slowed us down, but all is once again well. This week, we look at the often troubling intertwining of science and race: its long history, its ability to persist even during periods of disrepute, and the current forms it takes as it resurfaces, leveraging the internet and nationalism to buoy itself. We speak with Angela Saini, independent journalist and author of the new book "Superior: The Return of Race Science", about where race science went and how it's coming back.